These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34843967)

  • 1. Mechanistic insights into the interaction of cardiac sodium channel Na
    Xiong H; Bai X; Quan Z; Yu D; Zhang H; Zhang C; Liang L; Yao Y; Yang Q; Wang Z; Wang L; Huang Y; Li H; Ren X; Tu X; Ke T; Xu C; Wang QK
    Heart Rhythm; 2022 Mar; 19(3):478-489. PubMed ID: 34843967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insights into the interaction of the MOG1 protein with the cardiac sodium channel Na
    Yu G; Liu Y; Qin J; Wang Z; Hu Y; Wang F; Li Y; Chakrabarti S; Chen Q; Wang QK
    J Biol Chem; 2018 Nov; 293(47):18207-18217. PubMed ID: 30282806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy targeting protein trafficking regulator MOG1 in mouse models of Brugada syndrome, arrhythmias, and mild cardiomyopathy.
    Yu G; Chakrabarti S; Tischenko M; Chen AL; Wang Z; Cho H; French BA; Naga Prasad SV; Chen Q; Wang QK
    Sci Transl Med; 2022 Jun; 14(648):eabf3136. PubMed ID: 35675436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of calpastatin domain L to Na
    Zhang F; Xue Y; Su J; Xu X; Zhao Y; Liu Y; Hu H; Hao L
    Biochem Biophys Res Commun; 2022 Oct; 627():39-44. PubMed ID: 36007333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
    Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
    Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small GTPases SAR1A and SAR1B regulate the trafficking of the cardiac sodium channel Na
    Wang Z; Yu G; Liu Y; Liu S; Aridor M; Huang Y; Hu Y; Wang L; Li S; Xiong H; Tang B; Li X; Cheng C; Chakrabarti S; Wang F; Wu Q; Karnik SS; Xu C; Chen Q; Wang QK
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3672-3684. PubMed ID: 30251687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOG1 rescues defective trafficking of Na(v)1.5 mutations in Brugada syndrome and sick sinus syndrome.
    Chakrabarti S; Wu X; Yang Z; Wu L; Yong SL; Zhang C; Hu K; Wang QK; Chen Q
    Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):392-401. PubMed ID: 23420830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of sodium current caused by a Brugada syndrome-associated variant is determined by patient-specific genetic background.
    Martínez-Moreno R; Carreras D; Sarquella-Brugada G; Pérez GJ; Selga E; Scornik FS; Brugada R
    Heart Rhythm; 2024 Mar; 21(3):331-339. PubMed ID: 38008367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-Regulation of K
    Clatot J; Neyroud N; Cox R; Souil C; Huang J; Guicheney P; Antzelevitch C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.
    Aiba T; Farinelli F; Kostecki G; Hesketh GG; Edwards D; Biswas S; Tung L; Tomaselli GF
    Circ Cardiovasc Genet; 2014 Jun; 7(3):249-56. PubMed ID: 24795344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of human Na
    Li Z; Jin X; Wu T; Zhao X; Wang W; Lei J; Pan X; Yan N
    Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33712541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOG1: a new susceptibility gene for Brugada syndrome.
    Kattygnarath D; Maugenre S; Neyroud N; Balse E; Ichai C; Denjoy I; Dilanian G; Martins RP; Fressart V; Berthet M; Schott JJ; Leenhardt A; Probst V; Le Marec H; Hainque B; Coulombe A; Hatem SN; Guicheney P
    Circ Cardiovasc Genet; 2011 Jun; 4(3):261-8. PubMed ID: 21447824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
    Nieto-Marín P; Tinaquero D; Utrilla RG; Cebrián J; González-Guerra A; Crespo-García T; Cámara-Checa A; Rubio-Alarcón M; Dago M; Alfayate S; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Tamargo J; Bernal JA; Caballero R; Delpón E;
    Cardiovasc Res; 2022 Mar; 118(4):1046-1060. PubMed ID: 33576403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
    Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
    Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of Nedd4-2-binding capacity in PY-motif of Na
    Wang Y; Du Y; Luo L; Hu P; Yang G; Li T; Han X; Ma A; Wang T
    Acta Physiol (Oxf); 2020 Jun; 229(2):e13438. PubMed ID: 31900993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5.
    Wu L; Yong SL; Fan C; Ni Y; Yoo S; Zhang T; Zhang X; Obejero-Paz CA; Rho HJ; Ke T; Szafranski P; Jones SW; Chen Q; Wang QK
    J Biol Chem; 2008 Mar; 283(11):6968-78. PubMed ID: 18184654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.